Lymphoproliferative Disorders
📧 Sign up to get email alerts when something new happens for Lymphoproliferative Disorders.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases [Phase 2]
Phase 2 clinical trial evaluating tabelecleucel in EBV-associated diseases is active/not recruiting, focusing on EBV+ LPD and related condit…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies [Phase 2]
This update describes a Phase 2 pilot trial evaluating allogeneic blood or marrow transplantation for primary immunodeficiency disorders, wi…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies
This clinical trial entry describes a study to establish a tumor bank in families with multiple lymphoproliferative malignancies and is curr…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Comprehensive Register Of Lymphoproliferative Disorders (ReLy)
This trial registration update notes that the ReLy registry study for lymphoproliferative disorders is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma [Phase 2]
Phase 2 clinical trial evaluating allogeneic hematopoietic cell transplantation for peripheral T-cell lymphoma; recruitment is ongoing.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation [Phase 2]
A Phase 2 study evaluating allogeneic hematopoietic cell transplantation for disorders of T-cell proliferation and/or dysregulation, sponsor…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Chemogenomic Profiling in Hematological Malignancies (HEM-Profiling 2021) [NA]
A hematology-focused clinical trial update for HEM-Profiling 2021, currently recruiting to explore chemogenomic profiling across multiple le…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: Virtual Rehabilitation for Cancer Survivors [NA]
A clinical trial update indicates a virtual rehabilitation program for cancer survivors is currently recruiting across multiple cancer types…
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases [Phase 2]
This Phase 2 clinical trial update reports that the study evaluating Tabelecleucel for Epstein-Barr virus–associated diseases is currently r…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Pathogenesis of Hematologic Malignancies
An update on an ongoing clinical trial exploring the pathogenesis of hematologic malignancies, with enrollment by invitation at the sponsor …
-
EMA approval · 2025-11-24EMA Authorised: Ebvallo (tabelecleucel) — Pierre Fabre Medicament
The EMA authorised Ebvallo (tabelecleucel) for lymphoproliferative disorders; the therapy is developed by Pierre Fabre Medicament and design…
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition [Phase 2, Phase 3]
The update notes ongoing recruitment for the DETERMINE trial Arm 02 investigating atezolizumab in adults and pediatric/young adult patients …
-
CLINICAL_TRIALS research · 2025-10-27Clinical Trial Update: Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
This ClinicalTrials.gov update describes an ongoing study that collects tissue, blood, and body fluid samples from patients with hematologic…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity [Phase 2]
A Phase 2 clinical trial exploring allogeneic hematopoietic stem cell transplantation for patients with inborn errors of immunity is current…
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
This clinical trial update describes the use of the PET imaging agent 18F-fluorothymidine (18F-FLT) in cancer patients to assess tumor proli…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Registry of Older Patients With Cancer
This clinical trial registry entry from UNC Lineberger indicates an ongoing recruitment for a registry of older patients with cancer, includ…
-
CLINICAL_TRIALS trial_result · 2025-06-19Clinical Trial Update: Treatment and Natural History Study of Lymphomatoid Granulomatosis [Phase 2]
This is a Phase 2 clinical trial update reporting results for a treatment and natural history study of lymphomatoid granulomatosis; results …
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: Dose Escalation & Expansion Study of Oral VRx-3996 & Valganciclovir in Subjects With EBV+ Lymphoid Malignancies [Phase 1, Phase 2]
Phase 1/2 dose-escalation and expansion study of VRx-3996 with valganciclovir in Epstein-Barr virus-associated lymphoma and other EBV-relate…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: Plerixafor Harvesting And No Chemotherapy for Transplantation of Autologous STem Cells In Cancer (PHANTASTIC) [NA]
The PHANTASTIC trial evaluating plerixafor-assisted, chemotherapy-free autologous stem cell transplantation for cancer has completed.
-
CLINICAL_TRIALS research · 2025-02-03Clinical Trial Update: Oxford Pre-cancerous Lymphoproliferative Disorders Study
The clinical trial update indicates an active-but-not-recruiting study at the University of Oxford focused on pre-cancerous lymphoproliferat…
-
CLINICAL_TRIALS research · 2025-01-17Clinical Trial Update: Retrospective Observational Study of Italian Cohort of Lymphoma Patients (RETRO-LYMPH)
Retrospective observational study in Italy enrolling lymphoma patients to characterize clinical features and outcomes. The study also encomp…
-
CLINICAL_TRIALS trial_result · 2024-12-10Clinical Trial Update: CAR-NK Cells Production and Expansion From Patients With Lympho or Myeloproliferative Disorders and From Healthy Donors [NA]
Clinical trial update on producing and expanding CAR-NK cells from patients with lymphoproliferative or myeloproliferative disorders and fro…
-
CLINICAL_TRIALS withdrawal · 2024-12-05Clinical Trial Update: Preemptive Infusion of Donor Lymphocytes Depleted of TCR + T Cells + CD19+ B Cells Following ASCT [Phase 1]
A Phase 1 trial evaluating a preemptive infusion of donor lymphocytes depleted of TCR+ T cells and CD19+ B cells after autologous stem cell …
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Familial B-cell Lymphoproliferative Disorders
Clinical trial update from the University of Haifa on familial B-cell lymphoproliferative disorders, including monoclonal B-cell lymphocytos…
-
CLINICAL_TRIALS withdrawal · 2023-04-21Clinical Trial Update: A Study of Zilovertamab and Ibrutinib in Patients With Relapsed or Refractory Mantle Cell Lymphoma [Phase 3]
A Phase 3 trial combining Zilovertamab with Ibrutinib for relapsed or refractory mantle cell lymphoma has been withdrawn.